×

Danaher Total Liabilities and Share Holders Equity 2010-2024 | DHR

Danaher total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Danaher total liabilities and share holders equity for the quarter ending December 31, 2024 was $77.542B, a 8.22% decline year-over-year.
  • Danaher total liabilities and share holders equity for 2024 was $77.542B, a 8.22% decline from 2023.
  • Danaher total liabilities and share holders equity for 2023 was $84.488B, a 0.16% increase from 2022.
  • Danaher total liabilities and share holders equity for 2022 was $84.35B, a 1.4% increase from 2021.
Danaher Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $77,542
2023 $84,488
2022 $84,350
2021 $83,184
2020 $76,161
2019 $62,082
2018 $47,833
2017 $46,649
2016 $45,295
2015 $48,222
2014 $36,992
2013 $34,672
2012 $32,941
2011 $29,950
2010 $22,217
2009 $19,595
Danaher Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-12-31 $77,542
2024-09-30 $80,615
2024-06-30 $78,555
2024-03-31 $83,402
2023-12-31 $84,488
2023-09-30 $87,734
2023-06-30 $84,902
2023-03-31 $85,040
2022-12-31 $84,350
2022-09-30 $81,030
2022-06-30 $81,806
2022-03-31 $83,392
2021-12-31 $83,184
2021-09-30 $82,498
2021-06-30 $78,027
2021-03-31 $75,426
2020-12-31 $76,161
2020-09-30 $72,891
2020-06-30 $71,268
2020-03-31 $68,930
2019-12-31 $62,082
2019-09-30 $61,531
2019-06-30 $53,322
2019-03-31 $51,774
2018-12-31 $47,833
2018-09-30 $47,720
2018-06-30 $48,056
2018-03-31 $47,145
2017-12-31 $46,649
2017-09-30 $45,851
2017-06-30 $45,647
2017-03-31 $45,245
2016-12-31 $45,295
2016-09-30 $41,298
2016-06-30 $51,504
2016-03-31 $48,386
2015-12-31 $48,222
2015-09-30 $49,708
2015-06-30 $36,987
2015-03-31 $36,072
2014-12-31 $36,992
2014-09-30 $35,536
2014-06-30 $35,652
2014-03-31 $35,043
2013-12-31 $34,672
2013-09-30 $33,721
2013-06-30 $33,109
2013-03-31 $32,469
2012-12-31 $32,941
2012-09-30 $31,585
2012-06-30 $31,171
2012-03-31 $30,421
2011-12-31 $29,950
2011-09-30 $30,618
2011-06-30 $31,513
2011-03-31 $23,035
2010-12-31 $22,217
2010-09-30 $21,498
2010-06-30 $20,079
2010-03-31 $19,881
2009-12-31 $19,595
2009-09-30 $19,162
2009-06-30 $18,322
2009-03-31 $17,673
Sector Industry Market Cap Revenue
Medical Medical Services $150.904B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $87.590B 11.69
CVS Health (CVS) United States $79.455B 11.63
Cencora (COR) United States $47.362B 17.19
DiDi Global (DIDIY) China $23.670B 0.00
Natera (NTRA) United States $20.908B 0.00
ICON (ICLR) Ireland $16.429B 14.61
Revvity (RVTY) United States $13.985B 23.45
BioMerieux (BMXMF) France $13.758B 0.00
Viatris (VTRS) United States $13.595B 4.19
Doximity (DOCS) United States $13.537B 70.40
Solventum (SOLV) United States $13.178B 0.00
Avantor (AVTR) United States $11.895B 17.47
CochLear (CHEOY) Australia $11.072B 0.00
Medpace Holdings (MEDP) United States $10.491B 27.26
EUROFINS SCIENT (ERFSF) Luxembourg $9.952B 0.00
HealthEquity (HQY) United States $9.484B 47.58
Charles River Laboratories (CRL) United States $8.719B 16.52
Sonic Healthcare (SKHHY) Australia $8.501B 0.00
Amplifon S.p.A (AMFPF) Italy $6.224B 31.72
Bausch + Lomb (BLCO) Canada $5.573B 25.50
Organon (OGN) United States $3.884B 3.96
Sotera Health (SHC) United States $3.814B 20.40
BrightSpring Health Services (BTSG) United States $3.382B 71.93
Surgery Partners (SGRY) United States $3.198B 36.46
Concentras Parent (CON) United States $2.951B 0.00
Alignment Healthcare (ALHC) United States $2.613B 0.00
GeneDx Holdings (WGS) United States $2.610B 316.67
Ardent Health Partners (ARDT) United States $2.014B 0.00
PACS (PACS) United States $1.980B 0.00
Progyny (PGNY) United States $1.961B 39.71
Teladoc Health (TDOC) United States $1.961B 0.00
GoodRx Holdings (GDRX) United States $1.845B 48.40
Premier (PINC) United States $1.690B 10.82
Agilon Health (AGL) United States $1.500B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Pediatrix Medical (MD) United States $1.346B 11.28
CareDx (CDNA) United States $1.146B 0.00
AMN Healthcare Services Inc (AMN) United States $1.026B 8.12
Establishment Labs Holdings (ESTA) $0.986B 0.00
Embecta (EMBC) United States $0.798B 5.47
Auna S.A (AUNA) Luxembourg $0.598B 0.00
SBC Medicals (SBC) United States $0.484B 0.00
MultiPlan (MPLN) United States $0.472B 0.00
Sonida Senior Living (SNDA) United States $0.472B 0.00
DocGo (DCGO) United States $0.453B 17.08
InnovAge Holding (INNV) United States $0.449B 0.00
Enhabit (EHAB) United States $0.406B 35.09
QDM (QDMI) Hong Kong, SAR China $0.335B 8.78
Nutex Health (NUTX) United States $0.314B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.253B 0.00
LifeMD (LFMD) United States $0.248B 0.00
Beauty Health (SKIN) United States $0.194B 0.00
Performant Healthcare (PHLT) United States $0.193B 0.00
Sera Prognostics (SERA) United States $0.140B 0.00
Biodesix (BDSX) United States $0.122B 0.00
So-Young (SY) China $0.116B 19.63
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
IceCure Medical (ICCM) Israel $0.078B 0.00
ModivCare (MODV) United States $0.071B 3.85
Oncology Institute (TOI) United States $0.064B 0.00
NeueHealth (NEUE) United States $0.061B 1.61
OncoCyte (OCX) United States $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Co-Diagnostics (CODX) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
Pheton Holdings (PTHL) China $0.014B 0.00
KindlyMD (KDLY) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.002B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00